- Home
- GTBP vs PRZO Comparison
GTBP vs PRZO Comparison
Compare GTBP & PRZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GTBP | PRZO |
|---|---|---|
| Founded | 1965 | 2014 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.7M | 18.6M |
| IPO Year | 2016 | 2022 |
Fundamental Metrics
Financial Performance| Metric | GTBP | PRZO |
|---|---|---|
| Price | $0.38 | $0.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 430.7K |
| Earning Date | 05-15-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.75 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.26 | $0.45 |
| 52 Week High | $2.29 | $2.15 |
Technical Indicators
Market Signals| Indicator | GTBP | PRZO |
|---|---|---|
| Relative Strength Index (RSI) | 41.12 | 44.75 |
| Support Level | $0.29 | $0.45 |
| Resistance Level | $0.46 | $0.57 |
| Average True Range (ATR) | 0.05 | 0.04 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 27.16 | 49.08 |
Price Performance
Historical ComparisonAbout GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.
About PRZO ParaZero Technologies Ltd.
ParaZero Technologies Ltd operates as an aerospace defense company focused on the development of smart, autonomous solutions for the manned and unmanned aerial systems (UAS) industry. The Company develops, manufactures, markets, and sells counter-UAS net-launching platforms designed to protect against hostile drones in both battlefield and urban environments, precision aerial delivery systems for military applications, and smart, autonomous parachute safety systems designed to enable safe flight operations over populated areas and beyond visual line-of-sight. The Company sells its products internationally.